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Abstract 
AIM: Increased thromboxane A2 and peroxynitrite are hallmarks of cerebral 
ischemia/reperfusion (I/R). Stimulation of thromboxane/prostaglandin receptors (TP) 
attenuates endothelium-derived hyperpolarization (EDH). We investigated whether 
EDH-type middle cerebral artery (MCA) relaxations following TP stimulation are altered 
after I/R and the influence of peroxynitrite.  
METHODS: Vascular function was determined by wire myography after TP stimulation 
with the thromboxane A2 mimetic 9,11-Dideoxy-9α,11α-methano-epoxy prostaglandin 
F2α (U46619) in MCA of Sprague-Dawley rats subjected to MCA occlusion (90 
min)/reperfusion (24 h) or sham operation, and in non-operated (control) rats. Some 
rats were treated with saline or the peroxynitrite decomposition catalyst 5,10,15,20-
tetrakis(4-sulfonatophenyl)prophyrinato iron (III) (20 mg kg-1). Protein expression was 
evaluated in MCA and in human microvascular endothelial cells submitted to hypoxia 
(overnight)/reoxygenation (24 h) (H/R) using immunofluorescence and immunoblotting.  
RESULTS: In U46619-preconstricted MCA, EDH-type relaxation by the proteinase-
activated receptor 2 agonist serine–leucine–isoleucine–glycine–arginine–leucine–NH2 
(SLIGRL) was greater in I/R than sham rats due to an increased contribution of small-
conductance calcium-activated potassium channels (SKCa), which was confirmed by 
the enlarged relaxation to the SKCa activator N-cyclohexyl-N-2-(3,5-dimethyl-pyrazol-1-
yl)-6-methyl-4-pyrimidinamine. I/R and H/R induced endothelial protein tyrosine 
nitration and filamentous-actin disruption. In control MCA, either cytochalasin D or 
peroxynitrite disrupted endothelial filamentous-actin and augmented EDH-type 
relaxation. Furthermore, peroxynitrite decomposition during I/R prevented the increase 
in EDH-type responses.  
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CONCLUSION: Following TP stimulation in MCA, EDH-type relaxation to SLIGRL is 
greater after I/R due to endothelial filamentous-actin disruption by peroxynitrite, which 
prevents TP-induced block of SKCa input to EDH. These results reveal a novel 
mechanism whereby peroxynitrite could promote postischemic brain injury.  
Keywords: actin; calcium-activated potassium channels; ischemia/reperfusion; 
KCa2.3; SKCa; thromboxane 
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Introduction 
The cerebrovasculature is continually exposed to various stimuli (e.g. high arterial 
pressure, ischemia) that can alter the physiological distribution of cerebral blood flow 
(CBF). Cerebral arteries possess mechanisms of autoregulation to maintain CBF and 
protect brain tissue during changes in perfusion pressure (Cipolla 2009). Both nitric 
oxide (NO) and endothelium-derived hyperpolarization (EDH) are two separate dilator 
pathways that operate simultaneously to regulate CBF. Several lines of evidence 
suggest that EDH-mediated responses persist or even increase when NO 
bioavailability is reduced in different pathological states, including cerebral ischemia-
reperfusion (I/R; Marrelli et al. 1999, Marrelli 2002, Cipolla et al. 2009). Compromised 
NO signalling is often associated with endothelial cell damage and platelet activation. 
Thus, EDH-mediated responses may act as a back-up mechanism to maintain 
endothelium-dependent vasodilation and homeostasis in the brain (Golding et al. 
2002).  
Acute ischemic stroke is a thrombo-inflammatory disorder involving excessive platelet 
activation (Chamorro 2009). To date, immediate thrombolysis with tissue plasminogen 
activator is the only pharmacological treatment effective in ischemic stroke (George & 
Steinberg 2015), but it can develop into progressive damage in a process called 
“reperfusion injury” (Coutts & Goyal 2009). Thromboxane A2 (TxA2) is one of the 
multiple factors released by activated platelets that can mediate further platelet 
recruitment, activation, and smooth muscle cell constriction, contributing to the 
prothrombotic state in I/R (Chamorro 2009). In addition, previous studies suggest a role 
of endothelial thromboxane/prostaglandin receptor (TP) stimulation in suppressing the 
small-conductance calcium-activated potassium (SKCa) channel component of EDH 
(Plane & Garland 1996, Crane & Garland 2004, McNeish & Garland 2007; McNeish et 
al. 2012, Gauthier et al. 2014). Thus, TxA2-induced attenuation of EDH-mediated 
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relaxation may represent an additional mechanism by which TxA2 could impair tissue 
perfusion, especially in disease states where NO is defective (Ellinsworth et al. 2014).  
TxA2 binds to TP in both smooth muscle and endothelial cells and triggers the 
RhoA/Rho kinase pathway, which is hyperactivated in the ischemic brain (Koumura et 
al. 2011), regulating many cellular functions including ion channel activity (Ghisdal et 
al. 2003, Luykenaar et al. 2009). Rho kinase activation is linked to inhibition of 
endothelial cell SKCa channel function in rat middle cerebral artery (MCA; McNeish et 
al. 2012, Gauthier et al. 2014), although the precise mechanism is still unknown. One 
possibility is that inhibition of SKCa channel function is dependent upon actin 
cytoskeleton remodelling (Gorovoy et al. 2005, Prasain & Stevens 2009). Therefore, 
we hypothesize that modulation of endothelial cell actin cytoskeleton is necessary for 
TP-dependent inhibition of SKCa channel function and EDH-type relaxation. 
Interestingly, I/R is associated with increased peroxynitrite formation and disruption of 
cerebral smooth muscle actin (Maneen et al. 2006, Maneen & Cipolla 2007, Coucha et 
al. 2013). Therefore, we also explored whether peroxynitrite alters the endothelial actin 
cytoskeleton, and interferes with TP-dependent inhibition of SKCa channel function. Our 
results suggest that increased peroxynitrite production during I/R leads to endothelial 
cell F-actin disruption, which prevents TP-induced block of SKCa channel input to EDH, 
increasing proteinase-activated receptor (PAR) 2-evoked EDH-type relaxation. These 
findings reveal a novel mechanism whereby EDH may compensate loss of NO-
mediated relaxation in prothrombotic disease states such as ischaemic stroke. We 
propose that these alterations, however, could have potential deleterious effects on the 
injured brain. 
 
Materials and Methods 
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Animals 
The animal studies are reported as recommended by the ARRIVE guidelines (Kilkenny 
et al. 2010) and the study is conforming with: Good publication practice in physiology. 
Acta Physiol (Oxf). 2015 Dec;215(4):163-4. One hundred and thirty-five adult male 
Sprague-Dawley rats (Harlan; 270 to 330 g body weight) were used. Rats were housed 
under a 12:12-h light-dark cycle, controlled environmental conditions of temperature 
and humidity, and provided with access to food and water ad libitum. All of the 
experiments were carried out under the Guidelines established by the Spanish 
legislation (RD 1201/2005) and according to the guidelines for the European 
Community Council Directive (2010/63/EU) for Protection of Vertebrate Animals Used 
for Experimental and other Scientific Purposes. Experiments were approved by the 
Ethics Committee of the Universitat Autònoma de Barcelona.  
 
Transient middle cerebral artery occlusion model  
Rats were anesthetized with isoflurane (3.5%) in a mixture of O2 and N2O (30:70). 
Focal brain ischemia was produced by 90-min intraluminal occlusion of the right MCA 
with reperfusion (24 h) as reported previously (Pérez-Asensio et al. 2010, Onetti et al. 
2015). Sham-operated (sham) rats were subjected to all the surgical procedures and 
the filament was introduced in the MCA and immediately removed. Cortical CBF, 
assessed with a laser–Doppler system (Perimed AB, Järfalla, Sweden), was monitored, 
and body temperature was maintained at 37 ± 0.5 °C during surgery. To produce 
analgesia, buprenorphine (0.01 mg kg-1) was administered subcutaneously 15 min 
before recovery from the anaesthesia. At 24 h after MCA occlusion, they were deeply 
anesthetized with isoflurane (5%) and decapitated. The presence of an infarcted area, 
assessed by 2,3,5-triphenyltetrazolium chloride (Sigma-Aldrich, St. Louis, MO, USA) 
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staining, was the criteria to determine that I/R was successful (Pérez-Asensio et al. 
2010, Onetti et al. 2015). In some experiments, non-operated rats of the same sex and 
body weight that were not subjected to surgery were used as controls. 
In a set of animals, rats were treated (i.p.) 10 min after the onset of ischemia with either 
the peroxynitrite decomposition catalyst 5,10,15,20-tetrakis(4-
sulfonatophenyl)prophyrinato iron (III)  (FeTPPS; 20 mg kg-1; Calbiochem, San Diego, 
CA, USA; Kunz et al. 2007, Coucha et al. 2013) or vehicle (saline). The dose used was 
previously shown to inhibit the peroxynitrite-induced F-actin protein tyrosine nitration-
effects on MCA myogenic function after I/R (Coucha et al. 2013). 
 
Middle cerebral artery preparation  
Brain was removed and placed in ice-cold Krebs-Henseleit solution (KHS - in mmol L-1: 
112.0 NaCl, 4.7 KCl, 2.5 CaCl2, 1.1 KH2PO4, 1.2 MgSO4, 25.0 NaHCO3, and 11.1 
glucose) continuously gassed with 95% O2 and 5% CO2. Segments of MCA (wire and 
pressure myography and immunofluorescence studies) were dissected and maintained 
in cold KHS. For immunofluorescence studies, arteries were fixed with 4% phosphate-
buffered paraformaldehyde (PFA; pH 7.4) for 1 h and washed in three changes of 
phosphate buffered-saline solution (PBS; pH 7.4). After clearing, arterial segments 
were placed in PBS containing 30% sucrose overnight, transferred to a cryomold 
(Bayer Química Farmacéutica, Barcelona, Spain) containing Tissue Tek OCT 
embedding medium (Sakura Finetek Europe, Zoeterwoude, The Netherlands), frozen 
in liquid nitrogen, and kept at −70 °C.  
 
Wire myography  
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MCA function was studied in vessels mounted on an isometric wire myograph (model 
410 A; Danish Myo Technology, Aarhus, Denmark) following the protocol described 
(McNeish et al. 2012, Gauthier et al. 2014). Constricted tone was induced with the 
stable TxA2 mimetic 9,11-Dideoxy-9α,11α-methano-epoxy prostaglandin F2α (U46619; 
30-100 nmol L-1; EMD Millipore, Billerica, MA, USA) or endothelin-1 (1-10 nmol L-1; 
Enzo Life Sciences Inc., Farmingdale, NY, USA). Contractions were maintained around 
60-80% of tone obtained with KCl (100 mmol L-1), before adding the relaxing agonists. 
Endothelial-dependent relaxations were obtained with the agonist of proteinase-
activated receptor (PAR) 2 serine–leucine–isoleucine–glycine–arginine–leucine–NH2 
(SLIGRL; 20 µmol L-1; Auspep, Tullamarine, Victoria, Australia), bradykinin (1 nmol L-1-
30 mmol L-1; Sigma-Aldrich, St. Louis, MO, USA), or the potent and selective activator 
of small-conductance calcium-activated potassium (SKCa) channels N-cyclohexyl-N-2-
(3,5-dimethyl-pyrazol-1-yl)-6-methyl-4-pyrimidinamine (CyPPA; 100 µmol L-1; Sigma-
Aldrich, St. Louis, MO, USA; Hougaard et al. 2007). A single concentration of SLIGRL 
was used to minimize potential desensitization of PAR2 (Hwa et al. 1996, Bucci et al. 
2005). Preliminary experiments showed that it was not possible to obtain reliable 
cumulative concentration-dependent MCA relaxations to CyPPA.  
The effects of the non-selective nitric oxide synthase inhibitor Nω-nitro-l-arginine 
methyl ester (l-NAME; 300 µmol L-1; Sigma-Aldrich, St. Louis, MO, USA), the 
nonselective cyclooxygenase (COX) inhibitor indomethacin (10 µmol L-1; Sigma-
Aldrich, St. Louis, MO, USA), the specific intermediate-conductance KCa (IKCa) channel 
blocker TRAM-34 (1 µmol L-1; Sigma-Aldrich, St. Louis, MO, USA), the specific SKCa 
channel blocker apamin (100 nmol L-1; Latoxan, Valence, France), or the IKCa and 
large-conductance KCa (BKCa) channel blocker charybdotoxin (100 nmol L
-1; Latoxan, 
Valence, France) on endothelium-dependent relaxation were investigated by their 
addition 30 min before vessel preconstriction. Concentrations of most inhibitors were 
chosen based on previous studies (McNeish & Garland 2007, McNeish et al. 2012, 
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Gauthier et al. 2014). Preliminary experiments were conducted to obtain the adequate 
concentration of the actin cytoskeleton disruptor cytochalasin D (50 nmol L-1; EMD 
Millipore, Billerica, MA, USA) that did not affect vessel preconstriction, and either 
cytochalasin D or another actin cytoskeleton disruptor latrunculin B (10 nmol L-1-1 µmol 
L-1; EMD Millipore, Billerica, MA, USA) were added 30 min before starting the 
experiment.  
The potent oxidizing and nitrating agent peroxynitrite (EMD Millipore, Billerica, MA, 
USA) was added 30 min before vessel preconstriction at a concentration of 5 µmol L-1 
to affect vascular KCa channel activity (Liu et al. 2002). Preliminary experiments were 
conducted to obtain the adequate concentration of the oxidation/nitration inhibitor 
epicatechin (1 µmol L-1; Sigma-Aldrich, St. Louis, MO, USA) and the cytoskeleton 
stabilizer jasplakinolide (100 nmol L-1; EMD Millipore, Billerica, MA, USA) that did not 
affect vessel preconstriction, and were added 10 min before addition of peroxynitrite 
and maintained during peroxynitrite incubation. Decomposed-peroxynitrite (5 µmol L-1) 
was also used and added 30 min before vessel preconstriction. The activity of 
peroxynitrite and its decay after decomposition was confirmed by spectrophotometry 
according to the method described by Balavoine & Geletti (1999). Briefly, consumption 
of pyrogallol red (6 µmol L-1; Sigma-Aldrich, St. Louis, MO, USA) by peroxynitrite (2 
µmol L-1), submitted or not to different conditions (no degradation, 4 h of light exposure, 
overnight incubation at 37 °C, overnight incubation at room temperature), was 
evaluated in the presence of diphenyl diselenide (Sigma-Aldrich, St. Louis, MO, USA), 
and absorbance was measured at 540 nm. 
 
Middle cerebral artery endothelial filamentous-actin staining  
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The ipsilateral MCA from sham, I/R or non-operated (control) rats was mounted in a 
small vessel pressure myograph (model P100; Danish Myo Technology, Aarhus, 
Denmark) following the protocol previously described (Onetti et al. 2015). Arteries from 
control rats were incubated (30 min) with cytochalasin D (50 nmol L-1) or peroxynitrite 
(5 µmol L-1). All arteries were set to 70 mmHg in 0 Ca2+-KHS, pressure-fixed with 4% 
PFA in 0.2 mol L-1 phosphate buffer (pH 7.2-7.4) for 45 min, and stored overnight in 
PFA (4%) at 4 °C. Pressured-fixed intact arteries were mounted on slides in a well that 
was made of silicon spacers (to avoid artery deformation) and were double stained with 
the filamentous (F)-actin dye Alexa Fluor® 568 Phalloidin (Thermo Fisher Scientific 
Inc., Kalamazoo, MI, USA), following the manufacturer's instructions, and the nuclear 
dye Hoechst 33342 (0.01 mg mL-1; Sigma-Aldrich, St. Louis, MO, USA). Arteries were 
imaged with a Leica TCS SP5 (Manheim, Germany) confocal system at x63, at 561-nm 
(F-actin) and 405-nm (nuclei). Two or more stacks of serial optical slices (0.4-µm thick), 
from different regions containing at least two endothelial cell nuclei, were captured in 
each arterial segment, starting at the first emerging endothelial cell and proceeding into 
the lumen of each artery. Every image was taken under identical conditions of zoom 
(x4.5), laser intensity, brightness, and contrast. 3D image analysis was performed with 
Imaris 8.1 Image Analysis software (Bitplane, Oxford Instruments, Abingdon, UK). We 
defined two cuboid regions of interest (ROI) per stack, coinciding with the nuclear and 
cytoplasmic region of an endothelial cell, which remained constant for each artery. The 
average fluorescence intensity and volume of F-actin objects within each ROI was 
measured in the Z-axis (8-µm stack depth).  
 
Microvascular endothelial cell culture and hypoxia/reoxygenation model 
Human microvascular endothelial cell (HMVEC) lines from two different batches were 
obtained from Thermo Fisher Scientific Inc. (Kalamazoo, MI, USA), maintained in 
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culture in phenol red-free DMEM-F12 supplemented with 10% (v/v) foetal bovine serum 
(FBS) and microvascular growth supplement (Thermo Fisher Scientific Inc., 
Kalamazoo, MI, USA), and incubated at 37 °C in a humidified atmosphere at 95% air 
and 5% CO2. Cells were plated onto 1% gelatine-coated culture dishes and studied 
before confluence between passages 5 and 7. To induce hypoxia/reoxygenation (H/R), 
culture medium was changed to charcoal-striped low-serum (1%) media and cells were 
placed inside a sealed chamber. Hypoxic conditions were created by injection in the 
chamber with 94% N2, 5% CO2 and 1% O2 and hypoxia incubation proceeded 
overnight. In normoxic conditions, cells were kept overnight in the humidified 
atmosphere incubator with charcoal-striped low-serum (1%) media. Following hypoxia, 
cells were washed with PBS, fresh supplemented with DMEM-F12 + 10% FBS and 
reoxygenated in the humidified atmosphere incubator to simulate reperfusion 
conditions (Koo et al. 2001). After 24 h of reoxygenation, HMVEC were treated with 
U46619 (100 nmol L-1) for 15 min. In a series of experiments, normoxic cells were 
treated with peroxynitrite (500 nmol L-1) for 2 h and processed accordingly to each 
experimental protocol. It was not possible to use the same concentration of 
peroxynitrite used in experiments of vascular function (5 µmol L-1), since this 
concentration considerably affected cell viability. 
 
Immunofluorescence 
The ipsilateral MCA from sham, I/R or control rats was used. Arteries from control rats 
were incubated with peroxynitrite (5 µmol L-1; 30 min; in KHS at 37 °C) before being 
processed for immunofluorescence studies. Frozen transverse sections (14-µm thick) 
of MCA were incubated (1 h) with a rabbit polyclonal antibody against SKCa channels 
(1:100; Alomone labs, Jerusalem, Israel) or nitrotyrosine (1:100; Millipore, Billerica, MA, 
USA). After washing, sections were incubated (45 min) with the secondary antibody 
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(1:200), a donkey anti-rabbit IgG conjugated to Cyanine 3 (Jackson ImmunoResearch 
Laboratories Inc., West Grove, PA, USA) at 37 °C. Sections were processed for 
immunofluorescence staining essentially as described (Onetti et al. 2015). The 
specificity of the immunostaining was verified by omission of the primary antibody and 
processed as above, which abolished the fluorescence signal.  
HMVEC grown on coverslips were washed with ice-cold PBS and fixed with 4% PFA. 
After permeabilization with 0.1% Triton X-100/0.1% bovine serum albumin in PBS for 5 
min and blockage with 10% horse serum in PBS for 15 min, cells were incubated in 
blocking solution for 1 h at room temperature with primary antibodies: SKCa channels 
(1:100; Alomone labs, Jerusalem, Israel) or nitrotyrosine (1:100; Millipore, Billerica, MA, 
USA). Following washes, cells were co-stained with fluorescence-conjugated phalloidin 
(10 µM; Sigma-Aldrich, St. Louis, MO, USA) for F-actin and deoxyribonuclease I (300 
nM; Thermo Fisher Scientific Inc., Kalamazoo, MI, USA) for globular (G)-actin, and 
secondary antibodies (1:500) Alexa Fluor 594 conjugated goat anti-rabbit for SKCa 
channels and Alexa Fluor 488 conjugated goat anti-rabbit (Thermo Fisher Scientific 
Inc., Kalamazoo, MI, USA) for nitrotyrosine. Coverslips were mounted on slides using 
ProLong Gold antifade reagent with DAPI (Thermo Fisher Scientific Inc., Kalamazoo, 
MI, USA), and visualized through a confocal microscope (Axiovert 2000, Carl Zeiss 
Iberia, S.L., Spain) with a x63 objective lens (Carl Zeiss Iberia, S.L., Spain). Images 
were taken from 15-20 cells per coverslip. 
 
Western blotting 
Equal amount of protein from each cell sample (25 µg) was resolved by SDS-PAGE on 
4-12% gels and electroblotted onto nitrocellulose. Membranes were incubated 
overnight at 4 °C in PBS with 0.1% (v/v) Tween 20 (PBST) containing 2% milk and 
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specified polyclonal rabbit primary antibodies (1:500) as follows: anti-SKCa channels 
(Alomone labs, Jerusalem, Israel); anti-nitrotyrosine (Millipore, Billerica, MA, USA); or 
anti HIF-1α (Millipore, Billerica, MA, USA). After incubation with horseradish 
peroxidase-labelled specific secondary antibodies in PBST containing 1% milk and 
additional washes, chemiluminescent signal was visualized by LAS4000 imaging 
system (Fujifilm, Barcelona, Spain). Densitometric analyses of Western blots were 
performed using a Mac Biophotonic ImageJ Software. All membranes were reblotted 
using a monoclonal antibody anti GAPDH (1:2500; Santa Cruz Biotechnology, Santa 
Cruz, CA, USA) as a loading control. Data were normalized to corresponding values of 
GAPDH densitometry.  
 
Endothelial cell filamentous/globular-actin measurements 
Cells were grown on 60 mm dishes and went through H/R and treatment processes as 
described above. Subsequently, cells were washed once in ice-cold PBS before lysis 
with actin stabilization buffer (Cytoskeleton, Denver, CO, USA) on ice for 10 min. Cells 
were dislodged by scraping and the entire extract was incubated at 37 °C for 10 min. 
Samples were ultra-centrifuged (100,000 g) for 1 h at 37 °C. The supernatant 
containing globular (G)-actin was recovered, and the pellet containing F-actin was 
solubilized with actin depolymerisation buffer (Cytoskeleton, Denver, CO, USA). 
Aliquots of supernatant and pellet fractions were separated on 4-12% SDS-PAGE gels 
and then immunoblotted with monoclonal anti-actin antibody (Cytoskeleton, Denver, 
CO, USA). Chemiluminescent signal was detected by chemiluminescent reagent 
according to the manufacturer's protocols (SuperSignal west pico, Thermo Fisher 
Scientific Inc., Kalamazoo, MI, USA), and visualized by LAS4000 imaging system 
(Fujifilm, Barcelona, Spain).  
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RhoA activation pull-down assay 
Cells were grown on 60 mm dishes. After H/R and treatment processes described 
above, cells were cross-linked with Coupling Buffer (0.01 mol L-1 sodium phosphate, 
0.15 mol L-1 NaCl; 20 µg mL-1 disuccinimidyl suberate; pH 7.2). Cells were washed 
twice in PBS, incubated for 10 min in Mg++ lysis buffer (MLB; 25 mmol L-1 HEPES, pH 
7.5, 150 mmol L-1 NaCl, 1% Igepal CA-630, 10 mmol L-1 MgCl2, 1 mmol L
-1 EDTA and 
2% glycerol). Cell lysates were harvested by scraping and nuclei were collected by 
centrifugation (5 min, 14,000 g, 4 °C). Equal amount of protein (50 µg) was incubated 
overnight at 4 °C with Rhotekin RBD agarose (Millipore, Billerica, MA, USA) containing 
65 µg of recombinant Rho binding domain protein in 50 µL of glutathione-agarose 
slurry. After 3 washes with MLB and proper elution by boiling in Laemmli reducing 
buffer, samples were separated on 4-12% SDS-PAGE gels and then immunoblotted 
with monoclonal anti-RhoA antibody (1:1000; Santa Cruz Biotechnologies, Santa Cruz, 
CA, USA). Cell extracts from a serum-starved state (low basal RhoA activity) were 
used as negative control. Positive controls were aliquots treated with 100 µmol L-1 of 
GTPγS non-hydrolyzable analog to activate RhoA. Pull-down signal was normalized by 
total RhoA signal in aliquots of cell lysates not loaded with Rhotekin RBD agarose.  
 
Statistical analysis 
Results are expressed as mean ± SEM of the number (n) of arteries from different 
animals or independent cell culture experiments indicated in the figure legends. 
Vasodilator responses were expressed as the percentage change of the previous tone 
calculated by subtracting resting tone from U46619 or endothelin-1 contraction. A two-
way ANOVA followed by Tukey's post-test was used, when appropriate. In the case of 
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one single factor, unpaired Student's t-test or one-way ANOVA followed by Tukey's 
post-test was used for two or more than two groups, respectively. Data analysis was 
carried out using GraphPad Prism version 4 software. A value of P < 0.05 was 
considered significant. 
 
Results 
Influence of U46619 stimulation on EDH-type MCA relaxation after I/R 
Endothelium-dependent relaxation to SLIGRL (20 µmol L-1) following preconstriction 
with U46619 (30-100 nmol L-1) was impaired in MCA from the ischemic ipsilateral 
(103.50 ± 3.64%; n = 15) compared to the non-ischemic contralateral hemisphere 
(124.62 ± 4.64%; P < 0.05; n = 12) or sham (128.76 ± 4.45%; P < 0.01; n = 24) 
vessels. However, when arteries were treated with l-NAME (300 µmol L-1) plus 
indomethacin (10 µmol L-1), SLIGRL evoked larger EDH-type relaxation in U46619-
preconstricted ipsilateral (P < 0.01), but not contralateral, MCA compared to sham (Fig. 
1a). All further experiments of arterial function involving I/R animals were performed in 
ipsilateral MCA. Bradykinin evoked concentration-dependent EDH-type relaxation in 
vessels preconstricted with U46619 that was similar between I/R and sham arteries 
(Figure S1). When MCA were preconstricted with endothelin-1 (1-10 nmol L-1), 
relaxations to SLIGRL were equally small in MCA from I/R (22.54 ± 9.55%; n = 5) and 
sham (34.29 ± 7.33%; n = 4) rats.  
 
Effect of KCa channel blockers on EDH-type MCA relaxation after I/R 
The specific IKCa channel blocker TRAM-34 (1 µmol L
-1) reduced SLIGRL relaxation in 
U46619-preconstricted MCA from both I/R and sham animals (Fig. 1b, c). However, the 
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degree of EDH-type relaxation was still greater (P < 0.05) in I/R than sham arteries. 
The specific SKCa channel blocker apamin (100 nmol L
-1) diminished (P < 0.001) EDH-
type relaxations in I/R, but not sham arteries. Addition of TRAM-34 plus apamin 
similarly reduced EDH-type relaxation in I/R and sham arteries. Comparing incubation 
of TRAM-34 alone with TRAM-34 plus apamin, EDH-type relaxation only decreased (P 
< 0.01) in the I/R group (Fig. 1b, c). In all groups, EDH-type responses were abolished 
in the presence of a combination of apamin with the IKCa and BKCa channel blocker 
charybdotoxin (100 nmol L-1; results not shown).  
 
Rho-mediated signal activation in HMVEC submitted to H/R  
Although H/R in isolated cells does not recapitulate all aspects of I/R injury, it provides 
an interesting model for studying the molecular mechanisms involved in the increased 
EDH-type relaxation in MCA after I/R. We submitted HMVEC to H/R, a cell culture 
model of I/R (Koo et al. 2001). As observed in Figure 2a and S2, expression of 
hypoxia-inducible factor 1α (HIF-1α) was higher in cells that have undergone H/R than 
in those kept in normoxia. These results suggest that our cell system is a suitable 
model for H/R in endothelial cells. Rho activation is an important regulator of the 
activity of some ion channels (Ghisdal et al. 2003, Luykenaar et al. 2009), which may 
play a role on TP-dependent inhibition of SKCa channel function in the endothelium 
(McNeish et al. 2012, Gauthier et al. 2014). We analysed GTP-bound RhoA levels as a 
measure of RhoA activation (Fig. 2b), and found that 15-min treatment with U46619 
increased RhoA activity in both control (P < 0.05) and H/R (P < 0.001) conditions. It is 
important to note that H/R per se did not modify RhoA activity, but markedly 
augmented (P < 0.01) RhoA activation following U46619 stimulation. These results 
suggest an exaggerated TP-mediated RhoA activation after H/R in comparison to 
control conditions.  
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SKCa channel expression   
To determine if I/R-induced increase in SKCa channel signalling is related to changes 
in SKCa channel levels, we measured SKCa channel protein expression in both 
HMVEC and rat MCA (Fig. 3). We observed that neither U46619 stimulation nor 
exposure to H/R altered SKCa channel protein levels in HMVEC, as assessed by 
Western blotting (Fig. 3a and S3). We also studied protein levels, assessed by 
immunofluorescence, of SKCa channels in HMVEC (Fig. 3b) and MCA cross sections 
from sham and I/R rats (Fig. 3c). SKCa channel fluorescence was similar in control 
and H/R HMVEC (Fig. 3b). Positive red immunofluorescence signal for SKCa 
channels was restricted to the adventitia and endothelial layers of the MCA, and was 
similar in sham and I/R arteries (Fig. 3c).  
 
Actin content and distribution  
The content and distribution of F- and G-actin in HMVEC is shown in Figure 4. 
Exposure of endothelial cells to H/R led to a decrease in F-actin fluorescence (Fig. 4a) 
that was paralleled by a marked decrease (P < 0.001) in the amount of F-actin (Fig. 
4b), while G-actin expression remained unaffected (Fig. 4a, b). No appreciable 
differences on F- and G-actin were observed after U46619 incubation when compared 
to its own control (Fig. 4a, b). Similar to H/R, exogenous peroxynitrite (500 nmol L-1) 
was able to reduce both the F-actin fluorescence (Fig. 4a) and the F/G actin ratio (Fig. 
4b) in HMVEC. In intact and pressurized MCA, endothelial F-actin object volume, but 
not fluorescence, was decreased (P < 0.05) in I/R versus sham arteries (Fig. 4c). 
Similarly, incubation of MCA from non-operated (control) rats with cytochalasin D (50 
Page 17 of 47 Acta Physiologica
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
32
33
34
35
36
37
38
39
40
41
42
43
44
45
46
47
48
49
50
51
52
53
54
55
56
57
58
59
60
For Peer Review
18 
 
nmol L-1) or peroxynitrite (5 µmol L-1) was without effect on F-actin fluorescence, but 
significantly diminished (P < 0.05) F-actin object volume (Fig. 4c).   
 
Effect of actin cytoskeleton disruption on EDH-type relaxation of control 
MCA 
The role of actin organization on EDH-type vasodilation following TP stimulation was 
evaluated by using different agents that disrupt actin cytoskeleton at doses that did not 
affect U46619-preconstriction. We first studied the effect of different concentrations of 
the actin filament assembly inhibitor latrunculin B (Spector et al. 1989) on EDH-type 
responses in MCA from non-operated (control) rats, as these arteries showed a similar 
EDH-type response following TP stimulation than sham arteries (Fig. 5). Latrunculin B 
did not modify the basal tone (Table S1), and induced a progressive decrease of EDH-
type relaxation in control arteries (Fig. 5a). We next tested the effect of cytochalasin D, 
an actin cytoskeleton-disrupting agent that acts by a different mechanism than 
latrunculin B. Cytochalasin D induces barbed end capping and, at higher doses, 
severing of actin filaments, which progressively depolymerize actin polymers 
(Wakatsuki et al. 2001). In contrast to latrunculin B, exposure of control arteries to 
cytochalasin D (50 nmol L-1) did potentiate (P < 0.01) EDH-type relaxation (Fig. 5b), 
without altering the basal tone (Table S1). The cytochalasin D-induced potentiation of 
the EDH-type response was significantly diminished by incubation of apamin and 
TRAM-34, alone or in combination (Fig. 5b). To confirm the presence of SKCa channel 
input to EDH, we selectively activated SKCa channels with CyPPA (100 µmol L
-1; 
Hougaard et al. 2007), which induced a higher (P < 0.01) relaxation in cytochalasin D-
incubated than control arteries (Fig. 5c). Lastly, addition of apamin significantly reduced 
(P < 0.001) CyPPA relaxation in cytochalasin D, but not in control (P = 0.220), arteries.  
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Detection of protein tyrosine nitration  
Immunofluorescent and Western blot analysis of protein tyrosine nitration showed an 
increase (P < 0.001) in nitrotyrosine fluorescence/expression in HMVEC exposed to 
H/R (Fig. 6a, b and S4), comparable to levels seen when cells were treated with 
peroxynitrite (500 nmol L-1; Fig. 6b). In MCA cross sections, a weak nitrotyrosine 
fluorescent signal was found in sham arteries, whereas after I/R, marked protein 
tyrosine nitration was observed in all three layers of the vessel wall, including the 
endothelial layer (Fig. 6c). Similar to I/R, exogenous incubation of control MCA with 
peroxynitrite (5 µmol L-1) also promoted marked protein tyrosine nitration of the vessel 
wall, including the endothelial lay r. 
 
Impact of exogenous peroxynitrite on EDH-type relaxation of control MCA 
Subsequent experiments examined the effect of peroxynitrite (5 µmol L-1) exposure on 
EDH-type relaxation after U46619 preconstriction in arteries from control rats (Fig. 7a, 
b). Incubation of MCA with peroxynitrite did not modify the basal tone (Table S1), but 
increased (P < 0.01) the SLIGRL-evoked EDH-type relaxation (Fig. 7a). Inhibition of 
protein oxidation/nitration with epicatechin (1 µmol L-1) or induction of F-actin 
stabilization with jasplakinolide (100 nmol L-1) was not associated with increased EDH-
type relaxation by peroxynitrite. In addition, exposure of control arteries to 
decomposed-peroxynitrite (5 µmol L-1), obtained by submitting peroxynitrite to 
overnight incubation at 37 °C (Figure S5), was unable to potentiate EDH-type 
responses (Fig. 7a). Peroxynitrite-induced potentiation of the EDH-type response was 
significantly diminished by incubation of apamin and TRAM-34, alone or in combination 
(Fig. 7b). In addition, EDH-type relaxation decreased (P < 0.05) when comparing 
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incubation of TRAM-34 alone with TRAM-34 plus apamin. Furthermore, CyPPA 
relaxation augmented (P < 0.01) after peroxynitrite, but not decomposed-peroxynitrite, 
exposure (Fig. 7c).  
 
Effect of catalytically decomposing endogenous peroxynitrite on EDH-
type MCA relaxation after I/R 
To determine the in vivo effect of peroxynitrite formed during I/R on EDH-type 
relaxation following TP stimulation in MCA, rats were treated with FeTPPS (20 mg kg-
1), a selective peroxynitrite decomposition catalyst (Kunz et al. 2007, Coucha et al. 
2013), or saline (vehicle; Fig. 7d, e). Body weight, body temperature and percentage 
changes in cortical CBF during surgery are shown in Table S2. I/R rats treated with 
vehicle showed a larger (P < 0.01) EDH-type relaxation than vehicle-treated sham or 
FeTPPS-treated I/R rats (Fig. 7d). Addition of TRAM-34 alone or TRAM-34 plus 
apamin reduced EDH-type relaxation in any group compared to non-treated arteries. 
Remarkably, comparing incubation of TRAM-34 alone with TRAM-34 plus apamin, 
EDH-type relaxation only significantly decreased (P < 0.001) in I/R rats treated with 
vehicle, suggesting the presence of SKCa channel input to EDH (Fig. 7d). Consistent 
with this, CyPPA-mediated relaxation was larger (P < 0.01) in MCA from vehicle-
treated I/R than sham rats, and this effect was prevented by apamin incubation or in 
vivo FeTPPS treatment (Fig. 7e). 
  
Discussion 
Results from the present study show that PAR2-evoked EDH-type relaxation is greater 
in U46619-preconstricted MCA of I/R compared to sham rats. We demonstrate that the 
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increased EDH-type relaxation of the MCA after I/R is due to the inability of TP 
stimulation to block the SKCa channel EDH. We propose that the underlying mechanism 
involves increased peroxynitrite production and endothelial cell F-actin disruption 
during I/R.  
An increase in EDH-type MCA relaxation of the basal tone to uridine 5’-triphosphate 
has been reported after cerebral I/R (Marrelli et al. 1999, Marrelli 2002). In the present 
study, I/R only potentiated EDH-type responses to SLIGRL in U46619-preconstricted 
arteries, suggesting the involvement of specific receptor activation. Similarly, PAR2 
signalling is unaltered with stroke in the MCA of stroke-prone spontaneously 
hypertensive rats (Smeda & McGuire 2007). Previous evidence suggests that 
increases in EDH-type MCA relaxation after cerebral I/R could be triggered by a 
mechanism involving KCa channels (Marrelli et al. 1999). These observations were 
followed by studies demonstrating that KCa channels mediate the EDH response in rat 
MCA (McNeish et al. 2005, McNeish et al. 2006). Thus, it is plausible that augmented 
EDH-type relaxation following I/R is achieved through an increase of KCa channel 
signalling. We demonstrate SKCa channels are expressed in the endothelial layer of rat 
MCA, consistent with previous observations (McNeish et al. 2006), and that SKCa 
channels are also detected within the adventitia. Interestingly, SKCa channel expression 
was unaltered after I/R, as reported in parenchymal arterioles branching from the MCA 
(Cipolla et al. 2009). 
When the MCA is able to synthesize NO, both IKCa and SKCa channels contribute to 
EDH responses. However, under NO-deprived (McNeish et al. 2006) or TP-stimulated 
(McNeish & Garland 2007) conditions, the SKCa channel component of EDH is blocked. 
SKCa channel activity can be restored by exposure to COX inhibitors or TP antagonists 
(McNeish & Garland 2007; McNeish et al. 2012, Gauthier et al. 2014), demonstrating a 
role for TP stimulation in suppressing SKCa channel function (Plane & Garland 1996, 
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Crane & Garland 2004, McNeish & Garland 2007). Indeed, U46619-preconstricted 
MCA from sham rats had no SKCa channel component to EDH-type relaxation. 
Surprisingly, we found that the SKCa channel input to EDH-type responses was 
restored after I/R, increasing EDH-type relaxation compared to sham arteries. Whilst 
following I/R there was still an IKCa channel component to EDH-type relaxation, SKCa 
appeared to be the dominant channel as apamin virtually abolished relaxation and the 
residual relaxations were not inhibited to a greater extent by additional blockade of IKCa 
channels. In addition, direct stimulation of SKCa channels with the selective SKCa 
channel activator CyPPA (Hougaard et al. 2007) induced a greater relaxation in I/R 
than sham arteries. Together, these findings suggest that I/R has direct effects on SKCa 
channel activity independent of other components of the EDH response, and thus we 
focussed on the effect of I/R on this channel throughout the rest of the study.  
Activity of ion channels in numerous tissues is regulated by the actin cytoskeleton and 
cytoskeletal elements are responsible for localization and clustering of channel 
molecules in the plasma membrane (Levina et al. 1994). We found that H/R causes 
disruption of actin filaments in isolated endothelial cells. In parallel, cytochalasin D-
induced depolymerisation of actin polymers (Spector et al. 1989, Wakatsuki et al. 
2001), but not latrunculin B-induced prevention of actin monomer polymerization 
(Spector et al. 1989), augments the SKCa channel input to EDH-type relaxation in the 
MCA. Furthermore, cytochalasin D also increased direct SKCa channel relaxation 
evoked by CyPPA. Together, these results suggest the presence of an intact 
endothelial cell actin cytoskeletal preformed network is essential to TP-dependent 
inhibition of SKCa channel-mediated relaxation. Similarly, an intact actin cytoskeleton is 
necessary for Rho kinase inhibition of smooth muscle cell delayed-rectifier potassium 
channel activity, thus facilitating cerebral artery depolarization and constriction 
(Luykenaar et al. 2009). As TP-dependent inhibition of SKCa channel function has also 
been associated with Rho kinase activation in rat MCA (McNeish et al. 2012), we 
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investigated if such regulation could be related to the effect of Rho kinase on 
reorganization of the endothelial cell actin cytoskeleton (Gorovoy et al. 2005, 
Luykenaar et al. 2009, Prasain & Stevens 2009). We found greater activation of Rho 
kinase after U46619 stimuli in endothelial cells that underwent H/R than those under 
normoxic conditions, although it was not able to restore the actin disruption observed. 
Clearly, more detailed examination is required to determine the mechanism by which 
endothelial cell actin cytoskeleton influences SKCa channel activity. However, correct 
SKCa channel anchoring to cytoskeleton-binding proteins is essential for channel 
trafficking and activity (Lu et al. 2009, Rafizadeh et al. 2014).   
I/R is often associated with increased generation of reactive oxygen and nitrogen 
species, which react rapidly to form peroxynitrite (Yasmin et al. 1997). Peroxynitrite is 
known to contribute to the brain ischemic tolerance and protection afforded by 
lipopolysaccharide preconditioning (Kunz et al. 2007). In addition, peroxynitrite directly 
affects BKCa activity (Brzezinska et al. 2000, Liu et al. 2002, Li et al. 2005) and alters 
function of other proteins by causing both oxidation and posttranslational nitration of 
tyrosine residues (Palomares & Cipolla 2011). Actin is a tyrosine-rich protein and 
cerebral artery smooth muscle F-actin nitration is observed in conditions of increased 
peroxynitrite production, such as I/R, leading to myogenic tone impairment in cerebral 
arteries (Maneen et al. 2006, Maneen & Cipolla 2007, Coucha et al. 2013). In the 
present study, we observed increased protein tyrosine nitration and decreased F/G-
actin ratio in HMVEC exposed to peroxynitrite that was similar to cells submitted to 
H/R. Furthermore, in rat MCA, endothelial protein tyrosine nitration was coupled to F-
actin fragmentation either after I/R or peroxynitrite exposure. Incubation of control 
arteries with peroxynitrite also prevented the U46619-induced block of SKCa component 
of EDH-type relaxation and even potentiated these responses, which were similar to 
those observed after I/R. It is unlikely that other substances derived from the 
peroxynitrite molecule could be responsible for these effects, as decomposed 
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peroxynitrite did not modify EDH-type relaxation. We then assessed if peroxynitrite 
generated during I/R was involved in augmenting MCA SKCa-mediated relaxation. Rats 
were treated with FeTPPS, a selective peroxynitrite decomposition catalyst (Coucha et 
al. 2013, Kunz et al. 2007), early after occlusion onset to avoid peroxynitrite effects 
before treatment. The MCA from rats submitted to I/R and treated with FeTPPS 
showed the U46619-induced block of SKCa channel relaxation, resulting in similar EDH-
type responses to the sham-vehicle group. Together, these findings suggest that 
peroxynitrite formed during I/R helps prevent loss of EDH-type relaxation following TP 
stimulation in the MCA, through a mechanism that involves the preservation of SKCa 
channel activity.  
It is not clear at this stage if peroxynitrite-induced disruption of endothelial F-actin is the 
only contributor to augmented EDH-type responses. Indeed, other oxidative stress-
derived molecules produced during I/R such as superoxide anion and hydrogen 
peroxide may potentially disrupt the actin cytoskeleton (Moldovan et al. 1999, Dalle-
Donne et al. 2001, Boardman et al. 2004). Besides, several studies suggest that 
oxidative stress can potentiate Ca2+ release from endothelial stores (Edwards et al. 
2008, Lock et al. 2012) and enhance endothelial KCa channel-induced relaxation 
(Edwards et al. 2008). Interestingly, I/R is associated with augmented endothelial Ca2+ 
responses in the rat MCA leading to increased EDH-type dilations to uridine 5’-
triphosphate (Marrelli 2002). Therefore, further studies are required to determine 
whether peroxynitrite or other oxidative stress-derived molecules produced during I/R 
are also capable of augmenting endothelial SKCa channel relaxations by potentiating 
Ca2+ release from endothelial stores. Finally, the present study has a few technical 
limitations that deserve attention. First, the changes observed in an isolated human 
microvascular endothelial cell line do not necessarily reflect those of the endothelial 
layer of a rat MCA, as, for instance, the vessel source and the isolation and culture of 
cells affect cell phenotype and function; and second, in our Western blot analysis of 
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SKCa channel expression, we were unable to detect the functional high molecular 
weight form of the channel, and additionally, we could not discard that SKCa channel 
structure/expression may differ in cultured HMVEC and intact rat MCA; and third, 
although we have used one of the rodent models that most closely resembles a human 
ischemic stroke, the disadvantages of the use of an animal stroke model should be 
considered (Fluri et al. 2015).  
Cerebral artery constriction can worsen brain damage during I/R, whereas dilation can 
decrease cerebrovascular resistance and contribute to blood-brain barrier disruption 
and oedema formation (Palomares & Cipolla 2011). For example, reactive hyperaemia 
(i.e. CBF increases above basal levels at reperfusion) has been associated with 
adverse events such as increased blood-brain barrier leakage, oedema and more 
severe brain damage in experimental (Pérez-Asensio et al. 2010, Onetti et al. 2015) 
and human (Yu et al. 2015) ischaemic stroke. Notably, reactive hyperaemia is coupled 
to exacerbated protein tyrosine nitration in brain parenchyma and MCA (Pérez-Asensio 
et al. 2010, Onetti et al. 2015). Similarly, the greater EDH-type relaxation induced by 
peroxynitrite under prothrombotic conditions may contribute to decrease 
cerebrovascular resistance, promoting further brain damage during I/R.  
In summary, we have demonstrated that the ability of TP stimulation to curtail EDH-
type relaxation evoked by PAR2 signalling is absent after I/R, which reveal a novel 
mechanism whereby EDH may compensate loss of NO-mediated relaxation in 
prothrombotic disease states such as ischaemic stroke (Chamorro 2009). While this 
response could be considered as a key mechanism to improve regional blood flow 
(Golding et al. 2002), it might also contribute to blood-brain barrier disruption and 
oedema formation. We therefore propose that peroxynitrite-induced augmented EDH-
type responses may constitute a previously unidentified mechanism involved in 
promoting neurovascular injury during I/R. The present experimental study support the 
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use of peroxynitrite decomposing/scavenging compounds as potentially effective 
therapeutic strategies in the treatment of postischemic brain injury.  
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Legends to figures 
 
Figure 1. Relaxation to SLIGRL (20 µmol L-1) in U46619 (30-100 nmol L-1)-
preconstricted MCA from sham and ischemia/reperfusion (I/R) rats in the presence of l-
NAME (300 µmol L-1) and indomethacin (10 µmol L-1) to isolate EDH-type relaxation in 
(a) sham and ipsilateral (ipsi) or contralateral (contra) to I/R arteries and (b) ipsilateral 
arteries in the absence and presence of the IKCa channel blocker TRAM-34 (1 µmol L
-1) 
or the SKCa channel blocker apamin (100 nmol L
-1), alone or in combination. (c) 
Representative tracings showing the isolated EDH-type responses evoked by SLIGRL 
in sham and I/R arteries. Data are shown as mean ± SEM from 13 sham, 9 ipsilateral 
I/R and 8 contralateral I/R arteries (a) or 12 sham control, 5 sham + TRAM-34, 5    
sham + apamin, 6 sham + TRAM-34 + apamin, 8 I/R control, 8 I/R + TRAM-34, 3 I/R + 
apamin and 7 I/R + TRAM-34 + apamin arteries (b) of different animals. *P < 0.05; **P 
< 0.01 vs. sham; †P < 0.05, ††P < 0.01, †††P < 0.001 vs. control; ‡‡P < 0.01 vs. TRAM-
34, by one (a) or two (b)-way ANOVA with Tukey’s post-test. 
Figure 2. Protein expression in an endothelial cell model of hypoxia/reoxygenation 
(H/R). (a) Western blot and densitometric analyses (bottom), normalized to the 
expression of GAPDH, of hypoxia-inducible factor 1α (HIF-1α) expression and (b) pull-
down assay (immunoblot) of Rho-mediated signal activation and densitometric 
analyses (bottom), normalized to total RhoA, in human microvascular endothelial cells 
exposed to H/R in the absence and presence of U46619 (100 nmol L-1). Data are 
shown as mean ± SEM from 6 independent experiments obtained in two batches of 
cells at different passages. ***P < 0.001 vs. control by Student's t-test (a); *P < 0.05, 
***P < 0.001 vs. non-treated or ††P < 0.01 vs. control + U46619 by two-way ANOVA 
with Tukey’s post-test (b). 
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Figure 3. SKCa channel expression. (a) Western blot and densitometric analyses 
(bottom), normalized to the expression of GAPDH, of SKCa channel expression in 
human microvascular endothelial cells exposed to hypoxia/reoxygenation (H/R) in the 
absence and presence of U46619 (100 nmol L-1). Data are shown as mean ± SEM 
from 6 independent experiments obtained in two batches of cells at different passages. 
(b) Representative photomicrographs of SKCa channel immunofluorescence (red) of 
confocal microscopic sections of human microvascular endothelial cells exposed to 
H/R (n = 4 independent experiments obtained in two batches of cells at different 
passages). Filamentous (F)-actin staining (green) is also shown. (c) Representative 
photomicrographs of SKCa channel immunofluorescence (red) of confocal microscopic 
MCA sections of rats submitted to ischemia/reperfusion (I/R; n = 4 arteries of different 
animals per group). Natural autofluorescence of elastin (green) and nuclear staining 
(blue) are also shown. EC, endothelial cell; AC, adventitial cell.  
Figure 4. Analysis of endothelial cell actin expression. (a) Representative 
photomicrographs of filamentous (F)- (red) and globular (G)-actin (green) 
immunofluorescence of confocal microscopic sections and (b) immunoblot and 
densitometric analyses (right) of F- relative to G-actin expression in human 
microvascular endothelial cells exposed to hypoxia/reoxygenation (H/R) or peroxynitrite 
(ONOO-; 500 nmol L-1). Nuclear staining (blue) is also shown. Data are shown as mean 
± SEM from 4-6 independent experiments obtained in two batches of cells at different 
passages. ***P < 0.001 vs. control non-treated by one-way ANOVA with Tukey’s post-
test. (c) Representative raw (left) and mask (right) 3D reconstructions and 
quantification of F-actin fluorescence (red) in confocal microscopic intact MCA stacks 
of serial optical slices of the endothelial layer of rats submitted to ischemia/reperfusion 
(I/R) or non-operated (control) rats incubated with cytochalasin D (CytD; 50 nmol L-1) or 
ONOO- (5 µmol L-1). Nuclear staining (blue) is also shown. Cuboid regions of interest 
are marked with a dotted white line. EC, endothelial cell; SMC, smooth muscle cell. 
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Data are shown as mean ± SEM from 4 sham, 3 I/R, 4 control + CytD and 4 control + 
ONOO- arteries of different animals. *P < 0.05 vs. sham by one-way ANOVA with 
Tukey’s post-test.  
Figure 5. Effect of incubation with actin cytoskeleton-disrupting agents on endothelium-
dependent relaxation in U46619 (30-100 nmol L-1)-preconstricted MCA from non-
operated (control) rats in the presence of l-NAME (300 µmol L-1) and indomethacin (10 
µmol L-1) to isolate EDH-type relaxation. (a) Concentration-dependent effects of 
latrunculin B (10 nmol L-1-1 µmol L-1) on SLIGRL (20 µmol L-1) relaxation. (b) Effects of 
cytochalasin D (CytD; 50 nmol L-1) on SLIGRL relaxation in the absence and presence 
of TRAM-34 (1 µmol L-1) or apamin (100 nmol L-1), alone or in combination. (c) 
Representative tracings (upper panels) and analysis (bottom panel) of SKCa channel-
mediated relaxation induced by the selective SKCa channel activator CyPPA (100 µmol 
L-1) in control or CytD-incubated arteries in the absence and presence of apamin. Data 
are shown as mean ± SEM from 6 control, 6 control + latrunculin B (10 nmol L-1), 5 
control + latrunculin B (100 nmol L-1) and 5 control + latrunculin B (1 µmol L-1) (a) or 8 
control, 5 control + CytD, 6 control + CytD + TRAM-34, 5 control + CytD + apamin and 
6 control + CytD + TRAM-34 + apamin (b) or 10 control, 7 control + apamin, 7 control + 
CytD and 8 control + CytD + apamin (c) arteries of different animals. *P < 0.05, **P < 
0.01 vs. control; ††P < 0.01, †††P < 0.001 vs. control + CytD by one-way ANOVA with 
Tukey’s post-test. 
Figure 6. Detection of protein tyrosine nitration. (a) Representative photomicrographs 
and quantification of nitrotyrosine immunofluorescence (red) of confocal microscopic 
sections and (b) Western blot and densitometric analyses (bottom), normalized to the 
expression of GAPDH, of nitrotyrosine expression in human microvascular endothelial 
cells exposed to hypoxia/reoxygenation (H/R) or peroxynitrite (ONOO-; 500 nmol L-1). 
Filamentous (F)-actin (green) and nuclear staining (blue) are also shown. 
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Representative examples of elevated nitrotyrosine immunofluorescence are indicated 
with arrows. Data are shown as mean ± SEM from 6 independent experiments 
obtained in two batches of cells at different passages. ***P < 0.001 vs. control by one-
way ANOVA with Tukey’s post-test. (c) Representative photomicrographs of 
nitrotyrosine immunofluorescence (red) of confocal microscopic MCA sections of rats 
submitted to ischemia/reperfusion (I/R) or MCA of non-operated (control) rats 
incubated with ONOO- (5 µmol L-1; n = 3 arteries of different animals per group). 
Natural autofluorescence of elastin (green) and nuclear staining (blue) are also shown. 
Nitro, nitrotyrosine; EC, endothelial cell.  
Figure 7. Effect of peroxynitrite (ONOO-; 5 µmol L-1) on endothelium-dependent 
relaxation in U46619 (30-100 nmol L-1)-preconstricted MCA from non-operated (control) 
rats (a, b, c) or from sham and ischemia/reperfusion (I/R) rats (d, e) in the presence of 
l-NAME (300 µmol L-1) and indomethacin (10 µmol L-1) to isolate EDH-type relaxation. 
(a) Effects of ONOO- on SLIGRL (20 µmol L-1) relaxation in the presence of the 
oxidation/nitration blocker epicatechin (EPICAT; 1 µmol L-1) or the actin filament 
stabilizer jasplakinolide (JASPK; 100 nmol L-1). The effect of decomposed ONOO- (DC-
ONOO-; 5 µmol L-1) is also shown. (b) Effects of ONOO- on SLIGRL relaxation in the 
absence and presence of TRAM-34 (1 µmol L-1) or apamin (100 nmol L-1), alone or in 
combination. (c) Representative tracings (upper panels) and analysis (bottom panel) of 
SKCa channel-mediated relaxation induced by CyPPA (100 µmol L
-1) in control, ONOO- 
or DC-ONOO--incubated arteries. (d) Effect of in vivo treatment with the ONOO- 
decomposition catalyst FeTPPS (20 mg kg-1) on SLIGRL-evoked EDH-type relaxation 
in the absence and presence of TRAM-34 or TRAM-34 plus apamin. (e) Effect of in 
vivo treatment with FeTPPS on SKCa channel-mediated relaxation to CyPPA in the 
absence and presence of apamin. Data are shown as mean ± SEM from 7 control, 7 
control + ONOO-, 4 control + DC-ONOO-, 6 control + ONOO- + EPICAT and 5 control + 
ONOO- + JASPK (a) or 6 control, 6 control + ONOO-, 5 control + ONOO- + TRAM-34, 6 
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control + ONOO- + apamin and 4 control + ONOO- + TRAM-34 + apamin (b) or 9 
control, 7 control + ONOO- and 3 control + DC-ONOO- (c) or 7 sham + vehicle control, 
7 sham + vehicle + TRAM-34, 5 sham + vehicle + TRAM-34 + apamin, 7 I/R + vehicle 
control, 5 I/R + vehicle + TRAM-34, 5 I/R + vehicle + TRAM-34 + apamin, 7 I/R + 
FeTPPS control, 6 I/R + FeTPPS + TRAM-34 and 7 I/R + FeTPPS + TRAM-34 + 
apamin (d) or 8 sham + vehicle, 6 I/R + vehicle, 3 I/R + vehicle + apamin and 5 I/R + 
FeTPPS (e) arteries of different animals. **P < 0.01 vs. control or vs. sham + vehicle; 
†P < 0.05, ††P < 0.01, †††P < 0.001 vs. control + ONOO- or vs. non-treated; #P < 0.05, 
##P < 0.01 vs. I/R + vehicle; ‡P < 0.05; ‡‡‡P < 0.001 vs. control + ONOO- + TRAM-34 or 
vs. I/R + vehicle + TRAM-34, by one (a, b, c, e) or two (d)-way ANOVA with Tukey’s 
post-test.  
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Supporting Information 
 
Additional Supporting Information may be found online in the supporting information tab 
for this article: 
Table S1. Differences (∆) in basal tone measured before and after (30 min) addition of 
drugs. 
Table S2. Body weight, body temperature and percentage changes in cortical cerebral 
blood flow (CBF), with respect to basal values, in rats submitted to ischemia (90 
min)/reperfusion (24 h) (I/R) and treated with 5,10,15,20-tetrakis(4-
sulfonatophenyl)prophyrinato iron (III) (FeTPPS) or vehicle. 
Figure S1. Concentration-dependent relaxation to bradykinin in U46619 (30-100 nmol 
L-1)-preconstricted MCA from sham and ischemia/reperfusion (I/R) rats in the presence 
of l-NAME (300 µmol L-1) and indomethacin (10 µmol L-1) to isolate endothelium-
derived hyperpolarization-type response. Data are shown as mean ± SEM from 8 sham 
and 6 I/R arteries of different animals 
Figure S2. Representative hypoxia-inducible factor 1α (HIF-1α) Western blot results in 
human microvascular endothelial cells exposed to hypoxia/reoxygenation (H/R) or 
peroxynitrite (ONOO-; 500 nmol L-1).   
Figure S3. Representative SKCa channel Western blot results in human microvascular 
endothelial cells exposed to hypoxia/reoxygenation (H/R) in the absence and presence 
of U46619 (100 nmol L-1). 
Figure S4. Representative nitrotyrosine Western blot results in human microvascular 
endothelial cells exposed to hypoxia/reoxygenation (H/R) or peroxynitrite (ONOO-; 500 
nmol L-1).   
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Figure S5. Spectrophotometric analysis of peroxynitrite (2 µmol L-1) oxidant activity 
and its decay after decomposition. Consumption of pyrogallol red (6 µmol L-1) by 
peroxynitrite, submitted or not to different conditions, was evaluated in the presence of 
diphenyl diselenide. Data are shown as mean ± SEM from 3 independent experiments 
per group. *P < 0.05 vs. no degradation, by two-way ANOVA. 
 
Page 40 of 47Acta Physiologica
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
32
33
34
35
36
37
38
39
40
41
42
43
44
45
46
47
48
49
50
51
52
53
54
55
56
57
58
59
60
For Peer Review
S
L
I
G
R
L
 
r
e
l
a
x
a
t
i
o
n
 
(
%
 
U
4
6
6
1
9
)
0
20
40
60
80
100
120(a)
(c)
Figure 1
(b)
S
L
I
G
R
L
 
r
e
l
a
x
a
t
i
o
n
 
(
%
 
U
4
6
6
1
9
)
0
20
40
60
80
100
120
sham
ipsi contra
**
sham
I/R
A
r
t
e
r
i
a
l
 
t
e
n
s
i
o
n
(
m
N
)
 
4
3
2
1
0
+ U46619
+ SLIGRL
+ TRAM-34
+ U46619
+ SLIGRL
4
3
2
1
0
4
3
2
1
0
+ SLIGRL
+ U46619+ U46619
4
3
2
1
0
+ SLIGRL
A
r
t
e
r
i
a
l
 
t
e
n
s
i
o
n
(
m
N
)
 
• •
• •
+ SLIGRL
+ apamin
+ U46619
4
3
2
1
0
+ U46619
4
3
2
1
0
•
**
*
†††
† ‡‡†††
+TRAM-34 +apamin +TRAM-34
+apamin
+ SLIGRL
+ TRAM-34 
+ apamin
+ U46619
4
3
2
1
0
+ TRAM-34 (1 µM) 
+ APAMIN (100 nM)
+ SLIGRL
+ U46619
4
3
2
1
0
•
•
+ SLIGRL
†††
††
•
control
control
I/R I/Rsham
Page 41 of 47 Acta Physiologica
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
32
33
34
35
36
37
38
39
40
41
42
43
44
45
46
47
48
49
50
51
52
53
54
55
56
57
58
59
60
For Peer Review
non-treated + U46619 + U46619
GTPRho
control H/R
control H/R
0.0
0.3
0.6
0.9
1.2
1.5
non-treated + U46619
*
***
G
T
P
R
h
o
 
/
 
R
h
o
A
††
(b)(a)
Total RhoA
Figure 2
HIF-1α
GAPDH
control H/R
non-treated
Page 42 of 47Acta Physiologica
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
32
33
34
35
36
37
38
39
40
41
42
43
44
45
46
47
48
49
50
51
52
53
54
55
56
57
58
59
60
For Peer Review
SKCa
GAPDH
control controlH/R H/R
+ U46619
(a)
Figure 3
sham I/R
non-treated
AC
EC
50 m
SKCa elastin nuclei
EC
AC20 m
(c)
(b)
control H/R
SKCa
F-actin
10 m 10 m
Page 43 of 47 Acta Physiologica
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
32
33
34
35
36
37
38
39
40
41
42
43
44
45
46
47
48
49
50
51
52
53
54
55
56
57
58
59
60
For Peer Review
control  
(b)(a) Figure 4F-actin
control
H/R
+ U46619
G-actin
nuclei
control + ONOO-
control + U46619
H/R  non-treated 
H/R + U46619
F-actinG-actin
control + ONOO-
(c)
control  non-treated 
sham I/R
control + ONOO-control + CytD
F-actin
nuclei
EC EC
SMC
co
ntr
ol 
no
n-t
rea
ted
co
ntr
ol 
+ U
46
61
9
H/
R 
no
n-t
rea
ted
H/
R 
+ U
46
61
9
co
ntr
ol 
+ O
NO
O
-
0.0
0.5
1.0
1.5
2.0
2.5
***
***
***
5 m
non-treated
F
-
a
c
t
i
n
 
o
b
j
e
c
t
 
v
o
l
u
m
e
/
R
O
I
(
m
3
)
sh
am I/R
co
ntr
ol 
+ C
ytD
co
ntr
ol 
+ O
NO
O
-
F
-
a
c
t
i
n
 
o
b
j
e
c
t
 
f
l
u
o
r
e
s
c
e
n
c
e
 
i
n
t
e
n
s
i
t
y
/
R
O
I
(
a
r
b
i
t
r
a
r
y
 
u
n
i
t
s
)
sh
am I/R
co
ntr
ol 
+ C
ytD
co
ntr
ol 
+ O
NO
O
-
0
50
100
150
Page 44 of 47Acta Physiologica
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
32
33
34
35
36
37
38
39
40
41
42
43
44
45
46
47
48
49
50
51
52
53
54
55
56
57
58
59
60
For Peer Review
**
†††
(b)(a)
(c)
**
+apamin +apamin
+ CyPPA
A
r
t
e
r
i
a
l
 
t
e
n
s
i
o
n
(
m
N
)
 
+ U46619 + U46619
+ CyPPA
4
3
2
1
0
4
3
2
1
0
control + CytD
• •
Figure 5
*
††
†††
†††
Page 45 of 47 Acta Physiologica
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
32
33
34
35
36
37
38
39
40
41
42
43
44
45
46
47
48
49
50
51
52
53
54
55
56
57
58
59
60
For Peer Review
(a) control H/R Figure 6
(c) sham I/R control + ONOO-
50 m
nitroelastin nuclei
ECEC
20 m
(b)
control H/R
control 
+ ONOO-
N
i
t
r
o
t
y
r
o
s
i
n
e
GAPDH
F-actin
nitro
nuclei
Page 46 of 47Acta Physiologica
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
32
33
34
35
36
37
38
39
40
41
42
43
44
45
46
47
48
49
50
51
52
53
54
55
56
57
58
59
60
For Peer ReviewS L
I
G
R
L
 
r
e
l
a
x
a
t
i
o
n
 
(
%
 
U
4
6
6
1
9
)
0
20
40
60
80
100
120
**
**
††
Figure 7 (a)
A
r
t
e
r
i
a
l
 
t
e
n
s
i
o
n
(
m
N
)
 
control + ONOO- + DC-ONOO-
+ CyPPA
+ U46619 + U46619
+ CyPPA
4
3
2
1
0
+ U46619
+ CyPPA
•
•
•
**
+ TRAM-34 + TRAM-34
+  apamin
‡‡‡
(d)
+apamin
**
(e)
(c)
##
‡
#
##
non-treated
##
**
‡
(b)
I/R + vehiclesham + vehicle I/R + FeTPPS
†
††
†††
†††
†
†
††
††
†††
†††
†††
Page 47 of 47 Acta Physiologica
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
32
33
34
35
36
37
38
39
40
41
42
43
44
45
46
47
48
49
50
51
52
53
54
55
56
57
58
59
60
